Moderna Faces $1 Billion Net Loss in Q1 2025 Amid Declining COVID-19 Vaccine Sales
Moderna reports a $1 billion net loss in Q1 2025, with revenues dropping to $108 million. The decline is attributed to reduced COVID-19 vaccine sales, but the company remains hopef...